Clinically relevant pharmacokinetic drug interactions with second-generation antidepressants: an update

E Spina, V Santoro, C D'Arrigo - Clinical therapeutics, 2008 - Elsevier
Background: The second-generation antidepressants include selective serotonin reuptake
inhibitors (SSRIs), serotonin and norepinephrine reuptake inhibitors (SNRIs), and other …

Clinically significant drug interactions with antidepressants in the elderly

E Spina, MG Scordo - Drugs & aging, 2002 - Springer
Pharmacological treatment of depression in old age is associated with an increased risk of
adverse pharmacokinetic and pharmacodynamic drug interactions. Elderly patients may …

Selective serotonin reuptake inhibitors

D Lochmann, T Richardson - … : From biogenic amines to new mechanisms …, 2019 - Springer
The first antidepressants were created by chance but brought the idea that central serotonin
agonism produced an antidepressant effect. SSRIs were the first class of psychotropic …

[KİTAP][B] Drug-drug interactions

AD Rodrigues - 2019 - books.google.com
Authored by renowned leaders in the field, this comprehensive volume covers all aspects of
drug-drug interactions, including preclinical, clinical, toxicological, and regulatory …

Metabolic drug interactions with new psychotropic agents

E Spina, MG Scordo, C D'Arrigo - Fundamental & clinical …, 2003 - Wiley Online Library
New psychotropic drugs introduced in clinical practice in recent years include new
antidepressants, such as selective serotonin reuptake inhibitors (SSRI) and 'third generation' …

Metabolic drug interactions between antidepressants and anticancer drugs: focus on selective serotonin reuptake inhibitors and hypericum extract

F Caraci, R Crupi, F Drago, E Spina - Current drug metabolism, 2011 - ingentaconnect.com
Different antidepressant drugs are currently used for the treatment of depression in cancer
patients, such as second-generation antidepressants and, recently, the extracts of …

Fluoxetine: a review of its therapeutic potential in the treatment of depression associated with physical illness

SM Cheer, KL Goa - Drugs, 2001 - Springer
Fluoxetine is a potent and selective inhibitor of neuronal serotonin (5-hydroxytryptamine)
reuptake. Fluoxetine reduces food, energy and carbohydrate intake and increases resting …

Selective serotonin reuptake inhibitors

SH Preskorn, R Ross, CY Stanga - Antidepressants: Past, present and …, 2004 - Springer
The selective serotonin reuptake inhibitors (SSRIs)(citalopram, escitalopram, fluoxetine,
fluvoxamine, paroxetine, and sertraline) are the most widely prescribed class of …

Reproducibility of the in vivo effect of the selective serotonin reuptake inhibitors on the in vivo function of cytochrome P450 2D6: an update (part II)

SH Preskorn - Journal of Psychiatric Practice®, 2003 - journals.lww.com
Downloaded from by BhDMf5ePHKbH4TTImqenVA+ lpWIIBvonhQl60EtgtdlLYrLzSPu+
hQedJnbNaXBf on 12/01/2023 defined as belonging both to the class of antidepressants (a …

Detrimental antidepressant drug–drug interactions: Are they clinically relevant?

S Preskorn, S Werder - Neuropsychopharmacology, 2006 - nature.com
This paper takes the position that detrimental drug–drug interactions (DDIs) involving
antidepressants are clinically relevant. In doing so, it begins with a definition of the terms …